Trials of the new coronavirus treatment developed by Southampton based company Synairgen at Southampton University Hospital have now moved into the next phase of clinical trials.

This new treatment has shown very promising results, reducing the odds that patients in hospital develop serious disease by almost 80% in initial trials.

I am pleased that Southampton researchers have produced this promising new treatment which could not be more welcome at this very challenging time.